Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,960
+$7,531 QoQ
Shares Held
764
+991.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 95 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. RNAC ranks #302 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in RNAC

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,960 764
2026-03-31 $429 70
2025-12-31 $6,530 906
2025-09-30 $370,187 36,222
2025-06-30 $190,135 18,300
2025-03-31 $31,432 2,385
2024-12-31 $97,823 5,462
2024-09-30 $47,359 2,938
2024-06-30 $75,978 2,813
2024-03-31 $43,259 66,554
2023-12-31 $79,374 115,206
2023-09-30 $135,906 128,216
2023-06-30 $96,877 86,499
2023-03-31 $105,427 75,848
2022-12-31 $85,250 75,444
2022-09-30 $124,251 75,764
2022-06-30 $98,249 75,000
2022-03-31 $99,820 81,156
2021-12-31 $302,132 92,679
2021-09-30 $348,664 83,814
2021-06-30 $342,520 81,943
2021-03-31 $361,762 79,948
2020-12-31 $236,220 77,961
2020-09-30 $1,303 526